A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Experimental Treatment Gaining Traction Online
Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are urged to message these accounts directly for source information, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where communities with thousands of members share comparison images, administration instructions and claims of rapid UK delivery. Sellers market the drug there before directing customers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Experts Voice Concerns
However, doctors and chemists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to individuals injecting products of uncertain source.
Some professionals said the demand for the experimental drug could be linked to the increasing price of approved weight loss treatments such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the British medical regulations.
Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach medicines, marketing, and consumer laws, risking penalties, prosecution or imprisonment.
Platform Reaction and Material Removal
According to TikTok, the platform has removed violative content and banned related hashtags and query recommendations. The company said it was committed to keeping the service secure and investing in strengthening compliance measures.
Digital Marketplace Activities
Research also discovered communities with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of users, populated with images of slimming results, positive reviews and detailed instructions for mixing or administering at residence.
After moments of joining one community, a vendor posted WhatsApp details, where the majority of purchases occur. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about weight, medical conditions or past usage.
Item Information and Costs
Inside these groups, posts show dark colored packages with Royal Mail stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with sterile water, or ready-to-use injectors typically priced at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for Telegram stated it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting materials they cannot confirm. Even if the science behind retatrutide is sound, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.
Her staff has previously encountered patients harmed by self-injection from unconfirmed sources. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be impure or improperly measured.”
Manufacturer Statement
A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to possibly serious health risks”.
